outer mitochondrial membrane lipid metabolism regulator OPA3
Zuletzt aktualisiert 27. Juni 2022
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Der OPA3 gene provides instructions for making a protein whose exact function is unknown. The OPA3 protein is found in structures called mitochondria, which are the energy-producing centers of cells. The OPA3 protein is thought to play a role in the organisation of the shape and structure of the mitochondria and in controlled cell death (apoptosis).
Normal function
Der OPA3 gene provides instructions for making a protein whose exact function is unknown. The OPA3 protein is found in structures called mitochondria, which are the energy-producing centers of cells. The OPA3 protein is thought to play a role in the organisation of the shape and structure of the mitochondria and in controlled cell death (apoptosis).
Conditions referring to this gene or chromosome
Other names
FLJ22187
FLJ25932
MGA3
MGC75494
OPA3 protein
OPA3_HUMAN
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
Related patient information and medicines

Patient information leaflet
Muskelschwäche
This leaflet looks at types of Muskelschwäche and discusses the wide range of problems which can cause them. Some of these causes are very common and others are very rare. The difference between these three types of muscle weakness is often vague and it is possible to have more than one of them. However, working out which one is the main problem.

Patient information leaflet
Kann ich Fenofibrat und Gabapentin zusammen einnehmen?
There are no known significant interactions between fenofibrate and gabapentin. These two medicines work in different ways and are processed by different organs in the body. Why this happens Fenofibrate is primarily broken down by the liver and affects blood fats (lipids). Gabapentin is not metabolised by the liver; it is filtered out of the body.

Patient information leaflet
Bewertung des kardiovaskulären Gesundheitsrisikos
A cardiovascular health risk assessment provides an accurate estimate of your risk of developing cardiovascular disease (eg, angina, heart attack, stroke or peripheral arterial disease) over the following 10 years, and provides an opportunity for you to make any changes that will reduce this risk. If you already have a cardiovascular disease or.

Patient information leaflet
Kann ich Anastrozol und Vitamin B12 zusammen einnehmen?
Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Suchen Sie einfach nach Ihren Medikamenten, um mögliche Wechselwirkungen und Empfehlungen dazu zu sehen. Disclaimer This information is for general educational.

Patient information leaflet
Mehrlingsschwangerschaft
Why does multiple pregnancy occur. There is now a strict restriction on the number of embryos put into the womb after fertility treatment. How is multiple pregnancy classified The amnion and the chorion are the membranes (layers von tissue) which surround and protect the growing fetus. The amnion is closest to the fetus, and the chorion is outside.

Patient information leaflet
Kann ich Kollagen und Omega-3 zusammen einnehmen?
In fact, they are often taken together to support skin, joint, and heart health. Why this happens Collagen is a protein that is broken down into amino acids in the digestive tract, while Omega-3 is a fatty acid. They use different pathways for absorption and metabolism in the body and do not interfere with how the other works. Always consult y....
Weiterführende Lektüre und Referenzen
- outer mitochondrial membrane lipid metabolism regulator OPA3; MedlinePlus, National Library of Medicine.
- Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001 Dec;69(6):1218-24. doi: 10.1086/324651. Epub 2001 Oct 19.
- Bagli E, Zikou AK, Agnantis N, Kitsos G. Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies. In Vivo. 2017 Jul-Aug;31(4):511-525. doi: 10.21873/invivo.11090.
- Grau T, Burbulla LF, Engl G, Delettre C, Delprat B, Oexle K, Leo-Kottler B, Roscioli T, Kruger R, Rapaport D, Wissinger B, Schimpf-Linzenbold S. A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network. J Med Genet. 2013 Dec;50(12):848-58. doi: 10.1136/jmedgenet-2013-101774. Epub 2013 Oct 17.
- Huizing M, Dorward H, Ly L, Klootwijk E, Kleta R, Skovby F, Pei W, Feldman B, Gahl WA, Anikster Y. OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. Mol Genet Metab. 2010 Jun;100(2):149-54. doi: 10.1016/j.ymgme.2010.03.005. Epub 2010 Mar 16.
- Li Y, Li J, Jia X, Xiao X, Li S, Guo X. Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy. PLoS One. 2017 Jan 12;12(1):e0170090. doi: 10.1371/journal.pone.0170090. eCollection 2017.
- Reynier P, Amati-Bonneau P, Verny C, Olichon A, Simard G, Guichet A, Bonnemains C, Malecaze F, Malinge MC, Pelletier JB, Calvas P, Dollfus H, Belenguer P, Malthiery Y, Lenaers G, Bonneau D. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet. 2004 Sep;41(9):e110. doi: 10.1136/jmg.2003.016576. No abstract available.
- Sergouniotis PI, Perveen R, Thiselton DL, Giannopoulos K, Sarros M, Davies JR, Biswas S, Ansons AM, Ashworth JL, Lloyd IC, Black GC, Votruba M. Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy. Neurogenetics. 2015 Jan;16(1):69-75. doi: 10.1007/s10048-014-0416-y. Epub 2014 Aug 27.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
27. Juni 2022 | Neueste Version
1 Feb 2019 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

